Hyalinizing Granuloma: An Unusual Case of a Pulmonary Mass by Brandão, Viviane et al.
Hindawi Publishing Corporation
Case Reports in Medicine
Volume 2010, Article ID 984765, 3 pages
doi:10.1155/2010/984765
Case Report
HyalinizingGranuloma: An Unusual Case of a PulmonaryMass
VivianeBrand˜ ao,1 EdsonMarchiori,1,2 Gl´ auciaZanetti,1 GuilhermeAbdalla,1 NinaVentura,1
Carolina Lamas Constantino,1 Mariana Leite Pereira,1 Pedro Martins,1 Rodrigo Canellas,1
Antonio Muccillo,1 andRomulo Varella de Oliveira1
1Department of Radiology, Rio de Janeiro Federal University, CEP 21941.913 Rio de Janeiro, Brazil
2Department of Radiology, Fluminense Federal University, CEP 24220.071 Rio de Janeiro, Brazil
Correspondence should be addressed to Edson Marchiori, edmarchiori@gmail.com
Received 5 March 2010; Accepted 7 May 2010
Academic Editor: Reda E. Girgis
Copyright © 2010 Viviane Brand˜ ao et al. This is an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly
cited.
We describe the case of pulmonary hyalinizing granuloma in a 34-year-old asymptomatic man who presented with a pulmonary
nodule apparent by chest radiography and computed tomography (CT). He had a history of previous treatment for tuberculosis.
His laboratory data were normal. Bronchoscopy and CT-guided percutaneous transthoracic ﬁne needle aspiration cytology were
inconclusive. The diagnosis was revealed after the histopathological examination of an open lung biopsy.
1.Introduction
Pulmonary hyalinizing granuloma (PHG) is a rare benign
lung disease characterized by ﬁbrosing nodules, consisting
of either unilateral or bilateral central whorled deposits of
lamellar collagen hyaline [1]. The exact etiology of this
condition is unknown [2], although an exaggerated immune
responsetotheantigenicstimulibyinfectionorautoimmune
process has been suggested [3, 4]. The clinical presentation
of PHG ranges from vague chest symptoms to no symptoms
at all. Chest radiography and computed tomography will
reveal single or multiple well-deﬁned nodules with a random
distribution in persons with PHG. There are few complica-
tions with PHG and the patients have an excellent prognosis
[5]. Because the symptoms are mild, most of the lesions are
incidental radiological ﬁndings and are not initially correctly
diagnosed. PHG should hence be included in the diﬀerential
diagnosis of patients with pulmonary nodules.
2. Case Presentation
A 34-year-old man without symptoms was referred to our
hospital to clarify an abnormal chest radiograph showing a
nodular pulmonary lesion. He was currently without symp-
toms, but had been treated two years prior for tuberculosis
after presenting with mild fever, nonproductive cough, and a
ﬁve-pound weight loss. There were no comorbidities and the
patient denied a history of smoking. Physical examination
revealed no abnormalities.
The chest radiography revealed a well-circumscribed
mass in the left lung. CT scans demonstrated a mass with
irregular borders, measuring approximately 6cm in diame-
ter, located in the upper segment of the lower lobe of the left
lung. The mass was heterogeneous with hypodense areas and
amorphous calciﬁcations. No mediastinal lymphadenopathy
was observed (Figure 1).
Pulmonary function tests revealed a mild obstructive
ventilatory disturbance. Laboratory data, including rheuma-
toid factor and antinuclear body, were normal. Bron-
choscopy was normal and mycobacterial and fungal cultures
of bronchoalveolar lavage ﬂuid were negative. Cytological
evaluation was negative for malignant cells. CT-guided
percutaneous transthoracic ﬁne needle aspiration cytology
of the pulmonary lesion was nondiagnostic. There was no
evidence of bacterial or fungal organisms in the collected
sample.
An open lung biopsy revealed a mass in the upper
segment of the lower lobe of the left lung and ﬁbrous
exudate, which was adhered to the pleural surface. The
histopathological ﬁndings mainly consisted of deposition of
hyaline tissue masses accompanied by sparse lymphocytic
inﬁltrate (Figure 2). There was no histological evidence for2 Case Reports in Medicine
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Figure 1: HRCT scans with mediastinal window (a)–(d) demonstrated a mass with irregular borders, measuring about 6cm in diameter,
with pleural extension and thickening of adjacent pleura, located in the upper segment of the left lower lobe. The mass was heterogeneous
with hypodense areas. Amorphous calciﬁcations were also present in the mass (c, d) (arrows).
(a) (b)
Figure 2: (a) Marked changes in lung architecture determinated by deposition of hyaline tissue masses accompanied by sparse
lymphocytic inﬁltrate that compresses and distorts the remaining bronchioles (hematoxilin-eosin stain; original magniﬁcation, x40). A
higher magniﬁcation (b) demonstrates that the mass is composed by hypocellular collagen lamellae (hematoxilin-eosin stain; original
magniﬁcation, x100).
infectious agents such as TB and fungal organisms. These
features were consistent with a diagnosis of pulmonary
hyalinizing granuloma.
The patient received no subsequent speciﬁc treatment
andheremainedasymptomatic.Therewasnoincreaseinthe
size of the mass as of the last outpatient followup, which was
performed two years after diagnosis.
3. Discussion
PHG is a rare ﬁbrosing nodular disease known to aﬀect
adults between the ages of 19 and 77 years. The mean
age of person aﬄicted with the disease is 44 years [1]a n d
there is no sex predilection or race predominance [2, 6].
The clinical symptoms of PHG are mild and nonspeciﬁc,
and may include cough, fever, fatigue, dyspnea, pleuritic
chest pain, sinusitis, and pharyngitis. Several patients are
completely asymptomatic with lesions only found through
routine screening examinations [1, 5, 7].
The etiology of PHG remains unclear. It has been pro-
posed that the nodules may represent an abnormal immune
response to infectious agents, such as tuberculous bacilli
and histoplasma organisms, or autoimmune process, since
many immune-mediated diseases appear in concordance
withPHG[1,2,4,5,7,8].Therehavebeenreportsofpatients
who were previously exposed to fungal or mycobacterialCase Reports in Medicine 3
diseases prior to contracting PHG [6]. Additionally, patients
presenting with immunologic abnormalities and elevated
serum markers of progressive autoimmune diseases, such
as antinuclear antibodies, rheumatoid factor, and positive
antiglobulintestsmaybemorepronetodevelopingPHG[8].
Sclerosingmediastinitis,retroperitonealﬁbrosis,rheumatoid
arthritis, posterior uveitis, Sjogren’s syndrome, hemolytic
anemia, and other diseases are often associated with PHG
[1]. It has been hypothesized that all of these conditions
may essentially represent the same reactive response of an
immunologic mechanism triggered by infectious agents [9].
Associations of PHG with lymphoproliferative disorders,
such as lymphoma and Castleman’s disease, have also been
described [3, 9].
Chest radiography and CT ﬁndings show solitary or,
more often, multiple randomly distributed, unilateral or
bilateral nodules and/or masses with well-deﬁned borders.
The nodules may be present with or, more commonly,
without calciﬁcation and are typically focal and irregular
[10]. The calciﬁed masses are more often multiple and
bilateral [10]. Though rare, cavitation has been reported
[10, 11]. Nodule size ranges from several millimeters to
15cm in diameter, with an average diameter of 2cm [9].
Adenopathy is usually not associated with this entity [1].
Diﬀerential diagnosis in PHG includes malignancy
(metastatic or primary), infection (septic emboli, tuber-
culosis, histoplasmosis, or other fungal infections), amy-
loidosis, rheumatoid nodules, Wegener’s granulomatosis,
sarcoidosis, lymphomatoid granulomatosis, and plasma cell
granuloma [3, 6–8, 10, 11]. When calciﬁed, sarcomatous
metastases (e.g., osteosarcoma, chondrosarcoma and giant
cell tumor) and carcinomatous metastases (e.g., mucin-
producing adenocarcinomas, thyroid cancer, and choriocar-
cinoma)shouldbeincludedinthediﬀerentialdiagnosis[10].
The aforementioned masses can be diﬀerentiated by their
clinical, biological, bacteriological, and histopathological
characteristics [8].
F-18 ﬂuordeoxyglucose positron emission tomography
(FDG-PET/CT) can reveal increased metabolic activity in
PHG lesions [12]. However, an accurate diagnosis of PHG
can only be made with histopathological examination [8].
Microscopically, the lesions are well-circumscribed and are
characterized by a dense network of concentric hyalinized
collagen in the center of perivascular lymphoplasmacytic
inﬁltrate that rariﬁes in the center of the nodule [5]. The
collagen is deposited in ropy, whorled collagen bundles
that are separated by clear spaces [8]. Congo red stain
with polarization and crystal violet stain can be positive
for amyloid, and the diagnosis of amyloidosis must be
considered. Amyloidosis can be ruled out using electron
microscopy because in PHG the hyaline lamellae consist
o fe l e t r o n d e n s e ,c o m p a c t ,a m o r p h o u sm a t e r i a l ,w h i c hi s
substantially diﬀerent from ﬁbrillar amyloid lesions [4, 8].
The prognosis for patients with PHG is generally
excellent with no signiﬁcant impact on longevity. Single
lesions tend to be stable and resection is often curative.
Some patients with multiple lesions may show progressive
enlargement of nodules and increased dyspnea [1, 5]. There
is no deﬁnitive treatment for multiple nodules, although
successful resolution of the nodules with the administration
of glucocorticoids has been reported [1, 5, 12, 13]. FDG-
PET/CT may demonstrate a decrease in metabolic activity
after corticosteroid treatment [12]. One case of recurrence
after resection was described [14].
In conclusion, PHG should be considered in the diﬀer-
ential diagnosis of pulmonary nodules or masses, even when
they are cavitary or contain calciﬁcations.
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